share_log

CBD Global Sciences Begins The Process Of Name Change In Keeping With 'Ever-Changing Industry'

CBD Global Sciences Begins The Process Of Name Change In Keeping With 'Ever-Changing Industry'

CBD Global Sciences启动更名进程,以适应不断变化的行业
Benzinga Real-time News ·  2022/03/15 23:20

CBD Global Sciences, Inc. (OTC:CBDNF) (CSE:CBDN) (Frankfurt:GS3) has begun the process to formally change its name from "CBD Global Sciences" to "Global Sciences Inc.," dropping CBD from its name.

CBD全球科学公司(场外交易代码:CBDNF)(CSE:CBDN)(法兰克福:GS3)已经开始正式将其名称从“CBD Global Sciences”更名为“Global Science Inc.”,将CBD从其名称中删除。

It will operate under the trade name "Global Sciences" until full shareholder and regulatory approval of the new name is received. This move comes with the opportunity to expand the company's focus to more than just CBD with recently discovered opportunities that it says will create value for its shareholders.

该公司将以“Global Sciences”的商标运营,直到获得新名称的正式股东和监管机构的批准。这一举措伴随着将公司的重点扩大到不仅仅是CBD的机会,最近发现的机会,它说将为其股东创造价值。

The name change will not impact the company's ability to increase revenues and profitability within the CBD and distribution industries, but rather will enhance its ability to better define itself as it explores other areas in the field of wellness sciences. When approved, the company's trading symbol will change accordingly.

更名不会影响该公司在CBD和分销行业增加收入和盈利的能力,但会增强其在探索健康科学领域的其他领域时更好地定义自己的能力。一旦获得批准,该公司的交易代码将相应更改。

Brad Wyatt, CEO of CBD Global Sciences stated, "In the ever-changing industry of CBD the team at Global Sciences has become accustomed to quickly pivoting to provide better value to its customers and shareholders. This change is the beginning of more exciting news that will be presented in the near term. We are still very active in the CBD landscape and presenting wins for our company with lower cost manufacturing and more points of distribution which will translate into increased revenues and improved profitability. We are very excited about 2022 and beyond for our company and its shareholders."

布拉德·怀亚特在不断变化的CBD行业中,Global Sciences的团队已经习惯于快速转向,为其客户和股东提供更好的价值。这一变化是近期将呈现的更令人兴奋的消息的开始。我们仍然非常活跃在CBD领域,以更低的制造成本和更多的分销点为我们的公司带来胜利,这将转化为收入的增加和盈利的改善。我们对2022年及以后为我们的公司及其股东感到非常兴奋。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发